Triterpenoid / neoplasms

Anti-tumor activity of AECHL-1, novel triterpenoid isolated from Ailanthus excelsa in vitro and in vivo

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF INVENTION This invention relates to a novel triterpenoid AECHIL-1, isolated from Ailanthus excelsa having anti tumor activity both in vitro and in vivo. BACKGROUND OF INVENTION The existing state of art in the treatment of cancer includes Chemotherapy that involves the administration of

Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION FIELD OF THE INVENTION This invention relates generally to pentacyclic triterpenoid compounds such as .alpha.-boswellic acid acetate, .beta.-boswellic acid acetate and their analogs which possess topoisomerase inhibitory, cell differentiation inducing and/or anti-cancer

Derivatives of triterpenoid acids and uses thereof

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to

Derivatives of triterpenoid acids and uses thereof.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to

Derivatives of triterpenoid acids and uses thereof

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to

Methods of treating diseases using triterpenoid acid derivatives

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to

Therapeutic composition for treating cancers

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The present disclosure relates to a therapeutic composition comprising a novel combination of triterpenoids for treating cancers, including drug-resistant cancers. 2. Description of Related Art Edible fungus has long been used as a nutritional

Treatment of subjects with multidrug-resistant cancer

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TECHNICAL FIELD The present invention relates in a first aspect to a method for treating a subject suffering from a multidrug-resistant cancer, i.e. a cancer with multidrug-resistant phenotype and, thus, a specific subgroup of subjects with cancer. The method comprises administrating a

Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The present disclosure relates to novel use of compounds isolated from Euphorbia neriifolia for manufacturing a medicament or a pharmaceutical composition for treating cancer and/or thrombocytopenia. 2. Description of Related Art The leaves

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid

Synthesis and use of anti-tumor drug LQC-Y

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TECHNICAL FIELD The present invention relates to chemistry and bioscience filed, and specifically relates to LQC-Y general structural formula and the synthesis and the use thereof. It is proved by pharmacological experiments that this kind of compounds have a notable anti-tumor effect. No toxic

Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

RELATED APPLICATIONS/INCORPORATION BY REFERENCE All documents cited or referenced herein ("herein cited documents"), and all documents cited or referenced in the herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any

Composition containing total triterpenoid sapogenins extracted from bamboo, and the preparation method and use thereof

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates generally to a composition containing total triterpenoid sapogenins extracted from bamboo, as well as the preparation method and use thereof. These triterpenoids are extracted from bamboo using CO.sub.2 Supercritical Fluid Extraction (SFE) technique.

triterpenoid/neoplasms

Anti-tumor activity of AECHL-1, novel triterpenoid isolated from Ailanthus excelsa in vitro and in vivo

Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers

Derivatives of triterpenoid acids and uses thereof

Derivatives of triterpenoid acids and uses thereof.

Derivatives of triterpenoid acids and uses thereof

Methods of treating diseases using triterpenoid acid derivatives

Therapeutic composition for treating cancers

Treatment of subjects with multidrug-resistant cancer

Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Synthesis and use of anti-tumor drug LQC-Y

Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts

Composition containing total triterpenoid sapogenins extracted from bamboo, and the preparation method and use thereof

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen